Skip to content
Tuesday, September 26, 2023
  • Staff Email
  • FAQs
  • facebook
  • twitter
MCAZ

MCAZ

Protecting your right to quality medicines and medical devices
MCAZ
MENUMENU
MENUMENU
  • Home
  • About Us
        • Who We Are
        • MCAZ Board Members
        • Corporate Governance
        • Tenders
        • Careers @ MCAZ
        • Privacy Policy
        • Client Service Charter
        • Board Charter
  • Regulatory Functions
        • Evaluation and Registration
          • Overview
          • Find A Registered Medicine
          • How to Register
          • Alternative Submission Pathways
          • Registered & Approved Medicines
          • Human Medicines Guidelines
          • Key timelines for the Evaluation and Registration
          • Important Information
          • Summary for Product Characteristics
        • Licensing and Enforcement
          • Overview
          • Licensing
          • Inspections
          • Import & Export
          • Product Defects & Recalls
          • Medicinal Cannabis
          • Enquiries
        • Pharmacovigilance and Clinical Trials
          • Current Projects
          • Pharmacovigilance Centre
          • Clinical Trials
          • WHO Pharmacovigilance Toolkit
          • Clinical Trial Public Registry Platform
        • Laboratory Services
          • Medical Devices Laboratory
          • Microbiology Laboratory
          • Chemistry Laboratory
        • Legal and Coperate Affairs
          • Overview
        • Procurement Section
          • Tenders
          • Request For Quotations
  • Online Services
        • Online Registers
        • ADR E-Reporting
          • Consumer Reporting
          • Healthcare Professional Reporting
        • Import/Export for Registered Medicines
        • e-Clinical Trials
        • Online Persons and Premises Renewals
        • Section 75 Authorisation
  • Publications
    • Annual Reports
    • Press Release
  • Vaccine Safety
  • Downloads
  • RCore Trainings
  • Contact Us

Download Category: Guidelines

MCAZ-PVCT-GL02-Rev-1_February 2022- PHARMACOVIGILANCE GUIDELINE FOR PHARMACEUTICAL INDUSTRY

MCAZ-PVCT-GL02-Rev-1_February 2022- PHARMACOVIGILANCE GUIDELINE FOR PHARMACEUTICAL INDUSTRY937 DownloadsDownload Now!Size: 622KB

View More MCAZ-PVCT-GL02-Rev-1_February 2022- PHARMACOVIGILANCE GUIDELINE FOR PHARMACEUTICAL INDUSTRY

MCAZ-PVCT-GL-04-Rev-1-February 2022 Guidelines for Clinical Trial Application and Authorization in Zimbabwe

MCAZ-PVCT-GL-04-Rev-1-February 2022 Guidelines for Clinical Trial Application and Authorization in Zimbabwe526 DownloadsDownload Now!Size: 2MBPublished: March 22, 2022

View More MCAZ-PVCT-GL-04-Rev-1-February 2022 Guidelines for Clinical Trial Application and Authorization in Zimbabwe

MCAZ PVCT GL-05 Rev 2_February 2022 Guideline for Good Clinical Practice

MCAZ PVCT GL-05 Rev 2_February 2022 Guideline for Good Clinical Practice413 DownloadsDownload Now!Size: 665KBPublished: March 10, 2022

View More MCAZ PVCT GL-05 Rev 2_February 2022 Guideline for Good Clinical Practice

GL03-Rev-0_May-2021-Guideline for Pharmacovigilance of COVID-19 Vaccine AEFI Safety Surveillance

GL03-Rev-0_May-2021-Guideline for Pharmacovigilance of COVID-19 Vaccine AEFI Safety Surveillance396 DownloadsDownload Now!Size: 4 MBPublished: February 17, 2022

View More GL03-Rev-0_May-2021-Guideline for Pharmacovigilance of COVID-19 Vaccine AEFI Safety Surveillance

Guidelines_for_Conducting_Good_Clinical_Practice_GCP_Inspections_in_Zimbabwe__Rev_0_May_2021

Guidelines_for_Conducting_Good_Clinical_Practice_GCP_Inspections_in_Zimbabwe__Rev_0_May_2021672 DownloadsDOWNLOADSize: 504KB

View More Guidelines_for_Conducting_Good_Clinical_Practice_GCP_Inspections_in_Zimbabwe__Rev_0_May_2021

Circular 16 of 2021 – Use of Ivermectin human oral formulations for prevention and or treatment of COVID 19

Circular 16 of 2021 – Use of Ivermectin human oral formulations for prevention and or treatment of COVID 19319 DownloadsDownload…

View More Circular 16 of 2021 – Use of Ivermectin human oral formulations for prevention and or treatment of COVID 19

Zimbabwe National Pharmacovigilance Policy Handbook

Zimbabwe National Pharmacovigilance Policy Handbook496 DownloadsDOWNLOADSize: 5,786KBPublished: December 4, 2021

View More Zimbabwe National Pharmacovigilance Policy Handbook

Pharmacy guidelines for investigational medical products Version 1 June 2020

Pharmacy guidelines for investigational medical products Version 1 June 2020861 DownloadsDOWNLOADSize: 487KBPublished: December 4, 2021

View More Pharmacy guidelines for investigational medical products Version 1 June 2020

e-PV External User Manual Revision 0_June 2020

e-PV External User Manual Revision 0_June 2020689 DownloadsDOWNLOADSize: 315KBPublished: December 4, 2021

View More e-PV External User Manual Revision 0_June 2020

Guidelines for the Notification of Medicinal Product Problem or Defect and Recall Procedure

Guidelines for the Notification of Medicinal Product Problem or Defect and Recall Procedure474 DownloadsDOWNLOADSize: 735KBPublished: December 4, 2021

View More Guidelines for the Notification of Medicinal Product Problem or Defect and Recall Procedure

Posts navigation

Page 1 Page 2 Next page

Recent Posts

Previous Next
  • 2022 Customer Complaints Trend Analysis Report
    2022 Customer Complaints Trend Analysis Report
    2022 Customer Complaints Trend...
    Read more
  • Microbial Identification System
    Microbial Identification System
      MCAZ’s Microbiology Lab...
    Read more
  • 2021 Customer Complaints Trend Analysis Report
    2021 Customer Complaints Trend Analysis Report
    2021 Customer Complaints Trend...
    Read more
  • 2020 Customer Complaints Trend Analysis
    2020 Customer Complaints Trend Analysis
    2020 Customer Complaints Trend...
    Read more
  • ZIMBABWE LIST OF COVID-19 EMERGENCY USE AUTHORISATIONS
    ZIMBABWE LIST OF COVID-19 EMERGENCY USE AUTHORISATIONS
    ZIMBABWE LIST OF COVID-19 EMER...
    Read more
  • Veterinary Medicines Zazibona
    Veterinary Medicines Zazibona
    The Veterinary Medicines Zazib...
    Read more
  • MCAZ Code of Ethics
    MCAZ Code of Ethics
    In pursuit of promoting high e...
    Read more
  • MCAZ Tender Advert 01042022
    MCAZ Tender Advert 01042022
    INVITATION TO COMPETITIVE BIDD...
    Read more
  • MCAZ Reliance Policy
    MCAZ Reliance Policy
    The Medicines Control Authorit...
    Read more
More from Latest News

Get E-PV Mobile Applications

Related Links

  • Staff Email
  • FAQs

MCAZ Facebook

Medicines Control Authority of Zimbabwe

5 days ago

Medicines Control Authority of Zimbabwe
The Authority hosted the Health Professions Authority Zimbabwe for a study tour. The study tour was focused on exchanging notes on the Automation process that the Authority is carrying out. ... See MoreSee Less

Photo

View on Facebook
· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Medicines Control Authority of Zimbabwe

2 weeks ago

Medicines Control Authority of Zimbabwe
The Authority has published the latest issues of the Medicines Bulletin. The bulletin is meant to keep the Authority's stakeholders informed on the latest developments in medicine regulation in Zimbabwe.It can be accessed on the link below: www.mcaz.co.zw/wp-content/uploads/2023/09/August-2023-Medicines-Information-Bulletin.pdf ... See MoreSee Less
View on Facebook
· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

MCAZ Twitter

Our Address

  • 106 Baines Ave, Harare, Zimbabwe
  • +263-242-736981/5; 708255; 792165;
  • 0772-145-191/2/3
  • Toll Free Econet : 08080641
  • Toll Free TelOne : 08004507
  • WhatsApp : 0718 855 934
  • mcaz@mcaz.co.zw
MCAZ | Copyright © 2023 Medicines Control Authority of Zimbabwe. All Rights Reserved.